» Articles » PMID: 27828870

Association of Chronic Kidney Disease with Periprocedural Myocardial Injury After Elective Stent Implantation: A Single Center Prospective Cohort Study

Overview
Specialty General Medicine
Date 2016 Nov 10
PMID 27828870
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Coronary artery disease (CAD) is the leading cause of mortality in patients with chronic kidney disease (CKD). Patients with CKD who undergo percutaneous coronary intervention (PCI) may have more ischemic events than patients without CKD. The aim of our study was to determine the incidence of periprocedural myocardial injury (PMI) after elective stent implantation in patients with CKD using the Third Joint ESC/ACCF/AHA/WHF PMI definition.In a single center prospective cohort study, we enrolled 344 consecutive patients who underwent elective PCI in a period of 39 months. Serum troponin I (cTnI) concentrations were measured at baseline and at 8 and 16 hours after PCI. Periprocedural increase of cTnI, according to the most recent PMI definition, was used to define both the presence and intensity of PMI. Patients were further stratified according to the estimated glomerular filtration rate (eGFR) using 4 variable Modification of Diet in Renal Disease (MDRD) equation: control group with eGFR >90 mL/min/1.73 m and the CKD group with eGFR < 90 mL/min/1.73 m, with further subdivision according to the CKD stage.We found no significant difference in the incidence as well as intensity of the PMI in the control (>90 mL/min/1.73 m) and the CKD group (<90 mL/min/1.73 m) both 8 and 16 hours after PCI. When the CKD patients were further subdivided according to their CKD stage, there was again no difference in the intensity or incidence of PMI compared to the control group. Further analyses of our data showed angina pectoris CCS IV, bare metal stent (BMS) implantation, and treatment with angiotensin-converting enzyme inhibitors (ACEI) as independent predictors of PMI. Furthermore, the presence of hypertension was inversely related to the occurrence of PMI.Applying the new guidelines for PMI and using the eGFR equation most suitable for our patients, we found no association between PMI and CKD. Further analyses showed other factors that could potentially influence the occurrence of PMI.

Citing Articles

Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study.

Sun S, Ou Y, Shi H, Luo J, Luo X, Shen Y J Int Med Res. 2020; 48(3):300060520907783.

PMID: 32228089 PMC: 7133405. DOI: 10.1177/0300060520907783.


Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions - is there an association?.

Stipinovic M, Percin L, Radonic V, Jerkic H, Jurin I, Letilovic T Medicine (Baltimore). 2019; 98(43):e16989.

PMID: 31651833 PMC: 6824666. DOI: 10.1097/MD.0000000000016989.


Evaluation of the impact of chronic kidney disease on the survival of octogenarian patients submitted to percutaneous coronary intervention.

de Franca J, Godoy M, Santos M, Pivatelli F, Neto W, De Souza Braite M Indian Heart J. 2018; 70(6):848-851.

PMID: 30580855 PMC: 6306356. DOI: 10.1016/j.ihj.2018.06.009.


Effects of remote ischemic preconditioning on contrast induced nephropathy after percutaneous coronary intervention in patients with acute coronary syndrome.

Zhou F, Song W, Wang Z, Yin L, Yang S, Yang F Medicine (Baltimore). 2018; 97(2):e9579.

PMID: 29480853 PMC: 5943865. DOI: 10.1097/MD.0000000000009579.

References
1.
Shenoy C, Boura J, Orshaw P, Harjai K . Drug-eluting stents in patients with chronic kidney disease: a prospective registry study. PLoS One. 2010; 5(11):e15070. PMC: 2993936. DOI: 10.1371/journal.pone.0015070. View

2.
Schaefer U, Kurz T, Bonnemeier H, Dendorfer A, Hartmann F, Schunkert H . Intracoronary enalaprilat during angioplasty for acute myocardial infarction: alleviation of postischaemic neurohumoral and inflammatory stress?. J Intern Med. 2007; 261(2):188-200. DOI: 10.1111/j.1365-2796.2006.01757.x. View

3.
Nienhuis M, Ottervanger J, Dikkeschei B, Suryapranata H, de Boer M, Dambrink J . Prognostic importance of troponin T and creatine kinase after elective angioplasty. Int J Cardiol. 2006; 120(2):242-7. DOI: 10.1016/j.ijcard.2006.10.002. View

4.
Parikh P, Jeremias A, Naidu S, Brener S, Lima F, Shlofmitz R . Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2012; 80(3):352-7. DOI: 10.1002/ccd.23394. View

5.
Bonz A, Lengenfelder B, Jacobs M, Strotmann J, Held S, Ertl G . Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism. Am Heart J. 2003; 145(4):693-9. DOI: 10.1067/mhj.2003.65. View